Shruti V. Bendre

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

University of Illinois Urbana-Champaign(Current)

University of Illinois Chicago

Shruti V. Bendre is an author at University of Illinois Urbana-Champaign specializing in oncology, nuclear receptor signaling pathways, and nuclear receptor signaling.

ORCID

Publications per year

2022–2025

Publications

Cholesterol-targeting Wnt–β-catenin signaling inhibitors for colorectal cancer

Ashutosh Sharma, Julian Zalejski, Shruti V. Bendre et al. · Nature Chemical Biology · 2025 · 16 citations · Full text

Medicine, Cancer Biology, Oncology +12

The nuclear receptor TLX (NR2E1) inhibits growth and progression of triple- negative breast cancer

Adam T. Nelczyk, Liqian Ma, Anasuya Das Gupta et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2022 · 15 citations · Full text

Medicine, Molecular Biology, Oncology +13

Development of NR0B2 as a therapeutic target for the re-education of tumor associated myeloid cells

Hashni Epa Vidana Gamage, Samuel T Albright, Amanda Smith et al. · Cancer Letters · 2024 · 13 citations · Full text

Life Sciences, Immunology, Oncology +17

1–3 of 3